Advertisement covers IDWeek 2016


HIV Research Preview for IDWeek 2016

October 20, 2016

Here's a look at some of the noteworthy HIV research being presented at IDWeek 2016 in New Orleans from Oct. 25 to 30. The conference features some of the latest science and research on infectious diseases -- including HIV and hepatitis C.

IDWeek 2016 is the fifth annual combined meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA) and the Pediatric Infectious Diseases Society (PIDS). Here's a sneak peak of some conference highlights to look forward to.

[Editor's Note 10/28/16: This article is being updated with links to our coverage as we post it.]

  • What's Hot in HIV Clinical Research [Link Updated; Read Our Session Recap]
    A staple at IDWeek, as the title suggests, this session will recap what is new in HIV clinical science, as well as HIV epidemiology. It will be presented by Carlos Del Rio, M.D., of Emory University Rollins School of Public Health. Read our summary >>
  • What's Hot in HIV Basic Research [Link Updated; Read Our Session Recap]
    Complementing the previous session, this presentation will review the latest in HIV basic science, pathogenesis and cure research. Irini Sereti, M.D., of the National Institute of Allergy and Infectious Diseases (NIAID), will present it. Read our summary >>
  • HIV State of the ART
    Another staple of IDWeek, this session will highlight the latest advances in antiretroviral therapy and what's to come. Of note, Joel Gallant, M.D., M.P.H., will review when and what to start and when to switch. Meanwhile, Ian Frank, M.D., will review what's new and what's next in treatment.
  • HIV Clinical Management
    In this session, researchers will present new findings on different aspects of HIV clinical management. Joseph Eron Jr., M.D., will present a study on retesting suspected low-level HIV viral load blips as a way to prevent extra clinic visits and reduce patient anxiety. Additionally, Gretchen Volpe, M.D., M.P.H., will present a study analyzing the effect of long-term omega-3 fatty acid supplementation on lipids and vascular function among individuals living with HIV.
  • HIV Inflammation and Immune Activation
    This session will address some of the concerns over ongoing inflammation in individuals living with HIV. Of note, one study will examine the relationship between vitamin D metabolites and inflammation in HIV.
  • HIV and Sexually Transmitted Infection Prevention
    Here, we'll see new data on condoms, behavioral research, treatment as prevention and other prevention interventions. One study will highlight the characteristics of individuals who acquire HIV despite regularly accessing health care and testing. Another study will look at the sexual risk behavior and viral suppression of HIV-positive individuals receiving care in New York City.

Warren Tong is the senior science editor for and

Follow Warren on Twitter: @WarrenAtTheBody.

Copyright © 2016 Remedy Health Media, LLC. All rights reserved.

Related Stories

What's Hot in HIV Cure Research?
Top Menu Items From the Boiling Cauldron of HIV Clinical Research

This article was provided by TheBodyPRO. It is a part of the publication IDWeek 2016.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.